PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your LossesMorningStar·1 day ago, 07:44 PMPRCT-4.90%
Procept BioRobotics to report Q2 results after market close, host conference callPUBT·Jul 14 at 03:06 PMPRCT-4.90%
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)Tip Ranks·Jul 6 at 09:45 PMPRCT-4.90%
Procept BioRobotics posts investor presentation outlining Aquablation growth strategy in BPH marketPUBT·Jun 29 at 12:16 PMPRCT-4.90%
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga_article·Jun 24 at 06:35 AMOGE+0.69%TTWO+0.61%
PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?Simplywall·Jun 23 at 02:03 AMPRCT-4.90%
PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook HoldsSimplywall·Jun 20 at 10:04 AMPRCT-4.90%
Top 3 Health Care Stocks You'll Regret Missing In Q2benzinga_article·Jun 18 at 05:02 AMIRTC+1.42%PRCT-4.90%
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursdaybenzinga_article·Jun 11 at 10:42 AMMKTX+2.08%PRCT-4.90%
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to Market Perform at Leerink PartnersMarket Beat·Jun 11 at 08:02 AMPRCT-4.90%
PROCEPT BioRobotics (PRCT) Is Up 5.7% After New WATER IV Trials Expand Aquablation Testing ScopeSimplywall·Jun 7 at 08:34 PMPRCT-4.90%
